187 related articles for article (PubMed ID: 37993474)
1. Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease.
Nazari E; Khalili-Tanha G; Asadnia A; Pourali G; Maftooh M; Khazaei M; Nasiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Sci Rep; 2023 Nov; 13(1):20489. PubMed ID: 37993474
[TBL] [Abstract][Full Text] [Related]
2. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.
Cao Y; Du Y; Jia W; Ding J; Yuan J; Zhang H; Zhang X; Tao K; Yang Z
Front Endocrinol (Lausanne); 2023; 14():1125829. PubMed ID: 36923221
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics and machine-learning screening for immune-related genes in diagnosing non-alcoholic fatty liver disease with ischemic stroke and RRS1 pan-cancer analysis.
Bao H; Li J; Zhang B; Huang J; Su D; Liu L
Front Immunol; 2023; 14():1113634. PubMed ID: 37090698
[TBL] [Abstract][Full Text] [Related]
5. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
6. Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease.
Jiang H; Hu Y; Zhang Z; Chen X; Gao J
Lipids Health Dis; 2023 Sep; 22(1):150. PubMed ID: 37697333
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract][Full Text] [Related]
8. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis.
Masarone M; Troisi J; Aglitti A; Torre P; Colucci A; Dallio M; Federico A; Balsano C; Persico M
Metabolomics; 2021 Jan; 17(2):12. PubMed ID: 33458794
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].
Li LY; Wu JX
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(40):3317-3322. PubMed ID: 34758532
[No Abstract] [Full Text] [Related]
10. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
Wang J; Liu H; Xie G; Cai W; Xu J
Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
Cao J; Zhong Q; Huang Y; Zhu M; Wang Z; Xiong Z
Biochem Biophys Res Commun; 2023 Dec; 686():149180. PubMed ID: 37922570
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling reveals key genes and pathways related to the development of non-alcoholic fatty liver disease.
Wang R; Wang X; Zhuang L
Ann Hepatol; 2016; 15(2):190-9. PubMed ID: 26845596
[TBL] [Abstract][Full Text] [Related]
13. ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD.
Corey KE; Pitts R; Lai M; Loureiro J; Masia R; Osganian SA; Gustafson JL; Hutter MM; Gee DW; Meireles OR; Witkowski ER; Richards SM; Jacob J; Finkel N; Ngo D; Wang TJ; Gerszten RE; Ukomadu C; Jennings LL
J Hepatol; 2022 Jan; 76(1):25-33. PubMed ID: 34600973
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease.
Zhang J; Wang L; Jiang M
Medicine (Baltimore); 2024 Feb; 103(8):e37185. PubMed ID: 38394483
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.
Perakakis N; Polyzos SA; Yazdani A; Sala-Vila A; Kountouras J; Anastasilakis AD; Mantzoros CS
Metabolism; 2019 Dec; 101():154005. PubMed ID: 31711876
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy.
Yan Q; Zhao Z; Liu D; Li J; Pan S; Duan J; Dong J; Liu Z
Front Endocrinol (Lausanne); 2022; 13():1032814. PubMed ID: 36387855
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential feature genes in non-alcoholic fatty liver disease using bioinformatics analysis and machine learning strategies.
Zhang Z; Wang S; Zhu Z; Nie B
Comput Biol Med; 2023 May; 157():106724. PubMed ID: 36898287
[TBL] [Abstract][Full Text] [Related]
18. A robust gene expression signature for NASH in liver expression data.
Hasin-Brumshtein Y; Sakaram S; Khatri P; He YD; Sweeney TE
Sci Rep; 2022 Feb; 12(1):2571. PubMed ID: 35173224
[TBL] [Abstract][Full Text] [Related]
19. Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysis.
Qi S; Wang C; Li C; Wang P; Liu M
Medicine (Baltimore); 2017 Aug; 96(32):e7743. PubMed ID: 28796060
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
